Pharmacogenomics
Pharmacogenetic Algorithm May Help Predict Opioid and Pain Risks After Lumbar Spine Surgery
Genetic profiling supports accurate prediction of postoperative opioid and pain complications after lumbar surgery.
MAY 3, 2026
AI Could Help Pharmacists Champion PGx Implementation
Pharmacogenomics implementation by pharmacists is expanding, with AI and decision support tools driving precision ...
NOVEMBER 16, 2025
AI Could Help Pharmacists Champion PGx Implementation
PGx implementation, led by pharmacists, is becoming commonplace in hospitals and health systems, and AI can assist ...
OCTOBER 17, 2025
Specialty Pharmacy Set To Meet the Challenges Of PGx Clinical Integration
Specialty pharmacists are well positioned to include pharmacogenomics in clinical workflow and improve patient ...
DECEMBER 13, 2024
Bringing Diversity to Pharmacogenomics
For Porscha Johnson, PharmD, CPGx, improving pharmacogenomics diversity is personal. Much of the data about the ...
OCTOBER 16, 2024
Promise and Hurdles in Personalized Medicine
Only slightly more than one-third of patients diagnosed with non-small cell lung cancer receive personalized ...
OCTOBER 16, 2024
PGx May Take Edge Off Pain Management
Amid the ever-growing toll of the opioid epidemic, chronic pain remains both discouragingly common and difficult to ...
SEPTEMBER 12, 2024
PGx Promising for Psychiatry, but no ‘Magic Bullet’
Despite the prevalence of psychiatric disorders—more than one in five U.S. adults live with a mental illness, ...
AUGUST 19, 2024
PGx a Tool for Honing Chemotherapy and Supportive Care
The burgeoning field of pharmacogenomics can inform chemotherapy dosing and supportive care in oncology, and ...
MARCH 14, 2024
Taking Pharmacogenomics Guidelines to Heart
Pharmacogenomics is a rapidly expanding field with new evidence and implications for cardiology practice, experts ...
FEBRUARY 23, 2024
Pharmacists Poised to Lead Pharmacogenomics Implementation
In 510 b.c., the Greek philosopher and mathematician Pythagoras recommended that his followers “be far from ...
JANUARY 8, 2024
Novel Gene Therapy Slashes LDL in Patients With Hypercholesterolemia
VERVE-101, a novel gene therapy using liquid nanoparticles to edit the PCSK9 gene, reduced LDL cholesterol ...
NOVEMBER 20, 2023
